Collective Feshbach scattering of a superfluid droplet from a mesoscopic two-component Bose-Einstein condensate

We examine the collective scattering of a superfluid droplet impinging on a mesoscopic Bose-Einstein condensate (BEC) as a target. The BEC consists of an atomic gas with two internal electronic states, each of which is trapped by a finite-depth external potential. An off-resonant optical laser field provides a localized coupling between the BEC components in the trapping region. This mesoscopic scenario matches the microscopic setup for Feshbach scattering of two particles, when a bound state of one sub-manifold is embedded in the scattering continuum of the other sub-manifold. Within the mean-field picture, we obtain resonant scattering phase shifts from a linear response theory in agreement with an exact numerical solution of the real time scattering process and simple analytical approximations thereof. We find an energy-dependent transmission coefficient that is controllable via the optical field between 0 and 100%.Comment: 4 Latex pages, including 4 figure

β-Barrel scaffolds for the grafting of extracellular loops from G-protein-coupled receptors

Owing to the difficulties in production and purification of G-protein-coupled receptors (GPCRs), relatively little structural information is available about this class of receptors. Here we aim at developing small chimeric proteins, displaying the extracellular ligand-binding motifs of a human GPCR, the Y receptor. This allows the study of ligand-receptor interactions in simplified systems. We present comprehensive information on the use of transmembrane (OmpA) and soluble (Blc) β-barrel scaffolds. Whereas Blc appeared to be not fully compatible with our approach, owing to problems with refolding of the hybrid constructs, loop-grafted versions of OmpA delivered encouraging results. Previously, we described a chimeric construct based on OmpA displaying all three extracellular Y1 receptor loops in different topologies and showing moderate affinity to one of the natural ligands. Now, we present detailed data on the interaction of these constructs with several Y receptor ligands along with data on new constructs. Our findings suggest a common binding mode for all ligands, which is mediated through the C-terminal residues of the peptide ligand, supporting the functional validity of these hybrid receptors. The observed binding affinities, however, are well below those observed for the natural receptors, clearly indicating limitations in mimicking the natural system

β-Barrel scaffolds for the grafting of extracellular loops from G-protein-coupled receptors

Owing to the difficulties in production and purification of G-protein-coupled receptors (GPCRs), relatively little structural information is available about this class of receptors. Here we aim at developing small chimeric proteins, displaying the extracellular ligand-binding motifs of a human GPCR, the Y receptor. This allows the study of ligand-receptor interactions in simplified systems. We present comprehensive information on the use of transmembrane (OmpA) and soluble (Blc) β-barrel scaffolds. Whereas Blc appeared to be not fully compatible with our approach, owing to problems with refolding of the hybrid constructs, loop-grafted versions of OmpA delivered encouraging results. Previously, we described a chimeric construct based on OmpA displaying all three extracellular Y1 receptor loops in different topologies and showing moderate affinity to one of the natural ligands. Now, we present detailed data on the interaction of these constructs with several Y receptor ligands along with data on new constructs. Our findings suggest a common binding mode for all ligands, which is mediated through the C-terminal residues of the peptide ligand, supporting the functional validity of these hybrid receptors. The observed binding affinities, however, are well below those observed for the natural receptors, clearly indicating limitations in mimicking the natural system

Equivalence of Kinetic Theories of Bose-Einstein Condensation

We discuss the equivalence of two non-equilibrium kinetic theories that describe the evolution of a dilute, Bose-Einstein condensed atomic gas in a harmonic trap. The second-order kinetic equations of Walser et al. [PRA 63, 013607 (2001)] reduce to the Gross-Pitaevskii equation and the quantum Boltzmann equation in the low and high temperature limits, respectively. These kinetic equations can thus describe the system in equilibrium (finite temperature) as well as in non-equilibrium (real time). We have found this theory to be equivalent to the non-equilibrium Green's function approach originally proposed by Kadanoff and Baym and more recently applied to inhomogeneous trapped systems by M. Imamovi\'c-Tomasovi\'c and A. Griffin [arXiv:cond-mat/9911402].Comment: REVTeX3, 6 pages, 2 eps figures, published version, minor change

Legislation On The Preparation Of Medicinal Products In European Pharmacies And The Council Of Europe Resolution

The rights of patients should be sufficiently protected even when an appropriate authorised medicine does not exist or is unavailable on the market. The Resolution, which was adopted by the Committee of Ministers of the Council of Europe in 2011, aims at harmonising quality and safety standards for pharmacy preparation of medicinal products in Europe.Two pillars of EU regulation and the exceptions to them The system of regulation of medicinal products is built upon two pillars: the marketing authorisation of the medicinal product and the licence for manufacturing and wholesale. This article provides insight into the recent interpretation of the European Court of Justice concerning the scope of European Union (EU) regulation of medicinal products and the circumstances in which the EU regulation does not apply: pharmacy preparations, specialties and the compassionate use of medicines, including manufacturing licence.EU regulation and the Resolution concerning pharmacy preparation Pharmacy preparations are allowed under certain strict conditions according to EU regulations. However, pharmacies specialised in preparation and distributing medicinal products to local pharmacies do not fulfil these strict conditions in EU regulation. Apart from the legal context, relevant standards for safety and quality assurance are needed in Europe in order to protect patients’ rights and to avoid risks from pharmacy preparations.Discussion and conclusions The Council of Europe Resolution provides a means of establishing standards for safety and quality assurance for pharmacy preparations through Good Manufacturing Practice Guidelines. The Resolution is available to authorities and pharmacists in order to prevent incidents with medicines prepared in pharmacies which may threaten patients’ safety. The authors conclude that pharmacy practices have changed over time in Europe and this may imply a reason for a reform of EU regulation on medicinal products